TY  - GEN
AU  - Inwards,D J
AU  - Fishkin,P A
AU  - LaPlant,B R
AU  - Drake,M T
AU  - Kurtin,P J
AU  - Nikcevich,D A
AU  - Wender,D B
AU  - Lair,B S
AU  - Witzig,T E
TI  - Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma
SN  - 1569-8041
PY  - 2015///0611
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cladribine
KW  - Disease-Free Survival
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - pathology
KW  - Female
KW  - Humans
KW  - Lymphoma, Mantle-Cell
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Remission Induction
KW  - Rituximab
KW  - Sirolimus
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdu273
ER  -